150
Participants
Start Date
March 5, 2019
Primary Completion Date
March 31, 2020
Study Completion Date
March 31, 2020
TLC590
TLC590, a sustained-release formulation of the local anesthetics with lipid-based excipients
Naropin®
Local infiltration of Naropin to produce anesthesia for surgery and analgesia in postoperative pain management. 50 mg (0.5%, 10 mL)
Normal Saline
Normal Saline (0.9% sodium chloride, 10ml)
Bupivacaine
Bupivacaine 50 mg (0.5%, 10 mL)
Endeavor Clinical Trials, San Antonio
JBR clinical research, Draper
Arizona Research Center, Phoenix
Anaheim Clinical Trials, LLC, Anaheim
Chesapeake Research Group, Pasadena
Lead Sponsor
Taiwan Liposome Company
INDUSTRY